EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
50 hedge funds and large institutions have $120M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$12.7M | |
| 2 | +$8.32M | |
| 3 | +$7.4M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
+$3.46M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.84M |
Top Sellers
| 1 | -$4.68M | |
| 2 | -$1.13M | |
| 3 | -$549K | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$536K |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$452K |